search
Back to results

Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery (Catastim 2)

Primary Purpose

Neuromuscular Electrical Stimulation, Intensive Care Unit Acquired Weakness, Muscle Wasting

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Compex 3 Professional (CefarCompex Medical AB) stimulator
sham-stimulation
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neuromuscular Electrical Stimulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients before/after cardiothoracic surgery
  • ICU stay > 48 hours

Exclusion Criteria:

  • body mass index > 40 kg/m2
  • severe leg swelling
  • implanted ventricular assist device (RVAD, LVAD, BiVAD)
  • implanted intra-aortic balloon pump (IABP)
  • neuromuscular diseases
  • skin lesions in stimulation area
  • leg excluded if implant (hip or knee replacement) in stimulation area

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    NMES group

    Control group

    Arm Description

    Anterior muscles of both thighs were electrically stimulated twice a day (2×30 minutes of NMES with a break of at least 30 minutes between both sessions) 7 days a week during the entire ICU stay but no longer than 14 days, starting on postoperative day 1. Highest tolerable intensity was applied.

    In the control group, the electrodes were applied, connected to the stimulator, but no electricity was delivered.

    Outcomes

    Primary Outcome Measures

    Muscle layer thickness (MLT)
    Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
    Muscle strength
    Muscle strength using Medical Research Council (MRC) score and hand dynamometry

    Secondary Outcome Measures

    JAGS score
    JAGS score
    Timed Up and Go test
    Timed Get Up and Go test
    FIM score
    Functional Independance Measure (FIM) score
    SF-12 score
    12-item Short Form Health Survey (SF-12)

    Full Information

    First Posted
    March 7, 2015
    Last Updated
    July 6, 2015
    Sponsor
    Medical University of Vienna
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02391103
    Brief Title
    Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery
    Acronym
    Catastim 2
    Official Title
    Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    May 2011 (undefined)
    Primary Completion Date
    July 2012 (Actual)
    Study Completion Date
    March 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Medical University of Vienna

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purposes of this study are 1) to determine whether neuromuscular electrical stimulation (NMES) is effective in preventing loss of muscle mass and strength and 2) to observe the time variation of MLT and strength from preoperative day to hospital discharge.
    Detailed Description
    In the amendment of June 2011, a twofold study setting was defined in order to recruit patients not only before, but also after cardiothoracic surgery. In sample A, patients were recruited before surgery. In sample B, patients were recruited after surgery. On postoperative day 1, randomization was performed for sample A and B separately. To ensure balance of the NMES and control groups with respect to disease severity, randomization was stratified by the SAPS II score on the first postoperative day. In the intervention group, the anterior muscles of both thighs were electrically stimulated from the first postoperative day until ICU discharge for a maximum of 14 days. In the control group, the electrodes were applied, but no electricity was delivered.The primary outcomes muscle layer thickness (MLT) and muscle strength were assessed from the first postoperative day to ICU discharge and at hospital discharge. All patients in sample A had an additional assessment of MLT and strength before surgery. All data are analyzed according to the intention-to-treat principle with no imputation for any missing data. Linear mixed models are used to account for the repeated measurements per patient and to determine any fixed effects on MLT and MRC score.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Neuromuscular Electrical Stimulation, Intensive Care Unit Acquired Weakness, Muscle Wasting, Muscle Loss

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    54 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    NMES group
    Arm Type
    Experimental
    Arm Description
    Anterior muscles of both thighs were electrically stimulated twice a day (2×30 minutes of NMES with a break of at least 30 minutes between both sessions) 7 days a week during the entire ICU stay but no longer than 14 days, starting on postoperative day 1. Highest tolerable intensity was applied.
    Arm Title
    Control group
    Arm Type
    Sham Comparator
    Arm Description
    In the control group, the electrodes were applied, connected to the stimulator, but no electricity was delivered.
    Intervention Type
    Device
    Intervention Name(s)
    Compex 3 Professional (CefarCompex Medical AB) stimulator
    Intervention Description
    NMES
    Intervention Type
    Device
    Intervention Name(s)
    sham-stimulation
    Intervention Description
    no electricity applied
    Primary Outcome Measure Information:
    Title
    Muscle layer thickness (MLT)
    Description
    Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
    Time Frame
    on preoperative day, from postoperative day 1 onwards every other ICU day for the duration of the ICU stay (expected average of ICU stay: 7 days) and at day of hospital discharge (expected average of hospital stay: 20 days)
    Title
    Muscle strength
    Description
    Muscle strength using Medical Research Council (MRC) score and hand dynamometry
    Time Frame
    on preoperative day, from postoperative day 1 onwards every day for the duration of the ICU stay (expected average of ICU stay: 7 days), at day of hospital discharge (expected average of hospital stay: 20 days)
    Secondary Outcome Measure Information:
    Title
    JAGS score
    Description
    JAGS score
    Time Frame
    on preoperative day, on day of ICU discharge (expected average of ICU stay: 7 days), on day of hospital discharge (expected average of hospital stay: 20 days)
    Title
    Timed Up and Go test
    Description
    Timed Get Up and Go test
    Time Frame
    on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
    Title
    FIM score
    Description
    Functional Independance Measure (FIM) score
    Time Frame
    on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
    Title
    SF-12 score
    Description
    12-item Short Form Health Survey (SF-12)
    Time Frame
    on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patients before/after cardiothoracic surgery ICU stay > 48 hours Exclusion Criteria: body mass index > 40 kg/m2 severe leg swelling implanted ventricular assist device (RVAD, LVAD, BiVAD) implanted intra-aortic balloon pump (IABP) neuromuscular diseases skin lesions in stimulation area leg excluded if implant (hip or knee replacement) in stimulation area
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Michael Hiesmayr, MD, Prof.
    Organizational Affiliation
    Medical University of Vienna
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Arabella Fischer, MD
    Organizational Affiliation
    Medical University of Vienna
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    19814793
    Citation
    Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, Chatzimichail A, Routsi C, Roussos C, Nanas S. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care. 2009;13(5):R161. doi: 10.1186/cc8123. Epub 2009 Oct 8.
    Results Reference
    background
    PubMed Identifier
    23561945
    Citation
    Hirose T, Shiozaki T, Shimizu K, Mouri T, Noguchi K, Ohnishi M, Shimazu T. The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit. J Crit Care. 2013 Aug;28(4):536.e1-7. doi: 10.1016/j.jcrc.2013.02.010. Epub 2013 Apr 3.
    Results Reference
    background
    PubMed Identifier
    21715139
    Citation
    Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, Frosiani SL, Kozima S, Valentini R. Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation. J Crit Care. 2012 Jun;27(3):319.e1-8. doi: 10.1016/j.jcrc.2011.04.010. Epub 2011 Jun 28.
    Results Reference
    background
    PubMed Identifier
    25307979
    Citation
    Kho ME, Truong AD, Zanni JM, Ciesla ND, Brower RG, Palmer JB, Needham DM. Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015 Feb;30(1):32-9. doi: 10.1016/j.jcrc.2014.09.014. Epub 2014 Sep 22.
    Results Reference
    background
    PubMed Identifier
    21349913
    Citation
    Abdellaoui A, Prefaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J. 2011 Oct;38(4):781-8. doi: 10.1183/09031936.00167110. Epub 2011 Feb 24.
    Results Reference
    background
    PubMed Identifier
    20426834
    Citation
    Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, Markaki V, Zervakis D, Nanas S. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74. doi: 10.1186/cc8987. Epub 2010 Apr 28.
    Results Reference
    background
    PubMed Identifier
    12853536
    Citation
    Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003 Jul;124(1):292-6. doi: 10.1378/chest.124.1.292.
    Results Reference
    background
    PubMed Identifier
    25882765
    Citation
    Puthucheary ZA, Phadke R, Rawal J, McPhail MJ, Sidhu PS, Rowlerson A, Moxham J, Harridge S, Hart N, Montgomery HE. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting. Crit Care Med. 2015 Aug;43(8):1603-11. doi: 10.1097/CCM.0000000000001016.
    Results Reference
    background
    PubMed Identifier
    24108501
    Citation
    Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, Hopkinson NS, Phadke R, Dew T, Sidhu PS, Velloso C, Seymour J, Agley CC, Selby A, Limb M, Edwards LM, Smith K, Rowlerson A, Rennie MJ, Moxham J, Harridge SD, Hart N, Montgomery HE. Acute skeletal muscle wasting in critical illness. JAMA. 2013 Oct 16;310(15):1591-600. doi: 10.1001/jama.2013.278481. Erratum In: JAMA. 2014 Feb 12;311(6):625. Padhke, Rahul [corrected to Phadke, Rahul].
    Results Reference
    background
    PubMed Identifier
    26825278
    Citation
    Fischer A, Spiegl M, Altmann K, Winkler A, Salamon A, Themessl-Huber M, Mouhieddine M, Strasser EM, Schiferer A, Paternostro-Sluga T, Hiesmayr M. Muscle mass, strength and functional outcomes in critically ill patients after cardiothoracic surgery: does neuromuscular electrical stimulation help? The Catastim 2 randomized controlled trial. Crit Care. 2016 Jan 29;20:30. doi: 10.1186/s13054-016-1199-3.
    Results Reference
    derived

    Learn more about this trial

    Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery

    We'll reach out to this number within 24 hrs